1. Lindauer M, Stanislawski T, Haussler A, Antunes E, Cellary A, Huber C, Theobald M . The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes J Mol Med 1998 76: 32–47
2. Burnet FM . The concept of immunological surveillance Prog Exp Tumor Res 1970 13: 1–27
3. Gray JD, Hirokawa M, Horwitz DA . The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells J Exp Med 1994 180: 1937–1942
4. Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP . Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clin Cancer Res 1999 5: 2963–2970
5. Seo N, Tokura Y, Takigawa M, Egawa K . Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells J Immunol 1999 163: 242–249